Insmed Reports Third Quarter 2021 Financial Results and Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Insmed (INSM) Misses Q3 EPS by 12c; Reports Cash and Cash Equivalents of $846.6M
October 28, 2021 7:36 AM EDTInsmed (NASDAQ: INSM) reported Q3 EPS of ($0.96), $0.12 worse than the analyst estimate of ($0.84). Revenue for the quarter came in at $46.8 million versus the consensus estimate of $50.68 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
... More